Last updated on August 2020

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Brief description of study

The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in participants with moderately to severely active CD.

Clinical Study Identifier: NCT03104413

Find a site near you

Start Over

SIH Research, LLC /ID# 163081

Kissimmee, FL United States
  Connect »

Alliance Medical Research /ID# 163834

Lighthouse Point, FL United States
  Connect »

ITB Research /ID# 161278

Miami, FL United States
  Connect »

Advanced Research Institute /ID# 161973

New Port Richey, FL United States
  Connect »

IMIC Inc. /ID# 154944

Palmetto Bay, FL United States
  Connect »

Delricht Research /ID# 206567

New Orleans, LA United States
  Connect »

NY Scientific /ID# 158272

Brooklyn, NY United States
  Connect »

Tri-State Endoscopy /ID# 154939

Cincinnati, OH United States
  Connect »

Hightower Clinical /ID# 211992

Oklahoma City, OK United States
  Connect »

Gastro One /ID# 154757

Germantown, TN United States
  Connect »

Sagact Pllc /Id# 168772

San Antonio, TX United States
  Connect »

Cemic /Id# 168082

Buenos Aires, Argentina
  Connect »

Hospital Britanico de Buenos /ID# 168081

Ciudad Autonomade Buenos Aires, Argentina
  Connect »

Hopital Nord /ID# 162550

Saint Priest En Jarez, France
  Connect »

Hopital Saint Eloi /ID# 215146

Montpellier CEDEX 5, France
  Connect »

City Clinical Hospital # 31 /ID# 208865

St. Petersburg, Russian Federation
  Connect »

Mediclinic Milnerton /ID# 171172

CAPE TOWN,Milnerton, South Africa
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.